These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 7423252)
21. [Role of apoptosis in urothelial carcinoma. 1. Role of apoptosis in the development of urothelial carcinoma]. Savin M; Petronić V Srp Arh Celok Lek; 1999; 127(7-8):258-65. PubMed ID: 10624400 [No Abstract] [Full Text] [Related]
22. [Molecular changes in development and progression of urothelial carcinoma]. Hartmann A Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910 [TBL] [Abstract][Full Text] [Related]
24. Expression of caveolin-1 and caveolin-2 in urothelial carcinoma of the urinary bladder correlates with tumor grade and squamous differentiation. Fong A; Garcia E; Gwynn L; Lisanti MP; Fazzari MJ; Li M Am J Clin Pathol; 2003 Jul; 120(1):93-100. PubMed ID: 12866378 [TBL] [Abstract][Full Text] [Related]
25. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically. Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818 [TBL] [Abstract][Full Text] [Related]
26. Urothelial carcinoma of the upper urinary tract: inverted growth pattern is predictive of microsatellite instability. Hartmann A; Dietmaier W; Hofstädter F; Burgart LJ; Cheville JC; Blaszyk H Hum Pathol; 2003 Mar; 34(3):222-7. PubMed ID: 12673555 [TBL] [Abstract][Full Text] [Related]
27. Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder. Wright JL; Black PC; Brown GA; Porter MP; Kamat AM; Dinney CP; Lin DW J Urol; 2007 Dec; 178(6):2302-6; discussion 2307. PubMed ID: 17936803 [TBL] [Abstract][Full Text] [Related]
28. [The "proteomics forum". Interdisciplinary proteome research by the Essen University Clinic]. Goebell PJ; Rübben H; Müller G; Rettenmeier AW Urologe A; 2007 Sep; 46(9):1157-60. PubMed ID: 17605121 [No Abstract] [Full Text] [Related]
29. [Subsequent upper urothelial cancer following bladder tumor]. Kuruma H; Ao T; Murayama M; Mizoguchi H; Koshiba K Hinyokika Kiyo; 2002 Apr; 48(4):199-202. PubMed ID: 12048930 [TBL] [Abstract][Full Text] [Related]
30. [Evaluation of usefulness of urinary nuclear matrix protein 22 (NMP22) in the detection of urothelial transitional cell carcinoma]. Miyoshi Y; Matsuzaki J; Miura T Hinyokika Kiyo; 2001 Jun; 47(6):379-83. PubMed ID: 11496392 [TBL] [Abstract][Full Text] [Related]
31. [Association of uPA and uPAR expression with invasive behaviors of urinary transitional cell carcinoma]. Li YJ; Zheng BZ; Zhou ZL Ai Zheng; 2004 Jun; 23(6):704-6. PubMed ID: 15191676 [TBL] [Abstract][Full Text] [Related]
32. Detection of circulating cancer cells by reverse transcription-polymerase chain reaction for uroplakin II in peripheral blood of patients with urothelial cancer. Lu JJ; Kakehi Y; Takahashi T; Wu XX; Yuasa T; Yoshiki T; Okada Y; Terachi T; Ogawa O Clin Cancer Res; 2000 Aug; 6(8):3166-71. PubMed ID: 10955799 [TBL] [Abstract][Full Text] [Related]
33. [Sex identification of native and formalin fixed organ specimens by means of fluorescence optical determination of the Y chromatin]. Porstmann T; Schmechta H Z Arztl Fortbild (Jena); 1976 Jun; 70(12):666-8. PubMed ID: 997607 [No Abstract] [Full Text] [Related]
34. Numeric aberrations of HER-2 and chromosome 17 detected by fluorescence in situ hybridization in urine-exfoliated cells from patients with urothelial carcinoma. Inoue T; Sato K; Tsuchiya N; Matsuura S; Iinuma M; Habuchi T; Kato T Urology; 2004 Sep; 64(3):617-21. PubMed ID: 15351620 [TBL] [Abstract][Full Text] [Related]
35. [The clinical usefulness of urinary determinations of cytokeratin 19 fragment (CYFRA 21-1) in urothelial tumor]. Takeuchi S; Saitoh H; Yoshida K; Satake I; Tari K Hinyokika Kiyo; 1995 Aug; 41(8):589-92. PubMed ID: 7572437 [TBL] [Abstract][Full Text] [Related]
36. [Detection of urothelial carcinoma of the urinary bladder by multicolor fluorescence in situ hybridization]. Zhang YG; Bi XG; Han YL; Cai Y; Xu X; Wu YP; Yang YL; Ma JH; Zhao P; Jia XM; Wang MR Ai Zheng; 2007 Feb; 26(2):189-93. PubMed ID: 17298751 [TBL] [Abstract][Full Text] [Related]
37. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report. Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990 [TBL] [Abstract][Full Text] [Related]
38. [Significance of determination of sex chromatin in patients with carcinoma of the prostate]. Dunaevskiĭ IaL; Gumin LM Urol Nefrol (Mosk); 1977; (3):38-40. PubMed ID: 878086 [No Abstract] [Full Text] [Related]
39. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology. Alsheikh A; Mohamedali Z; Jones E; Masterson J; Gilks CB Mod Pathol; 2001 Apr; 14(4):267-72. PubMed ID: 11301341 [TBL] [Abstract][Full Text] [Related]
40. Urothelial neoplasms in patients 20 years or younger: a clinicopathological analysis using the world health organization 2004 bladder consensus classification. Fine SW; Humphrey PA; Dehner LP; Amin MB; Epstein JI J Urol; 2005 Nov; 174(5):1976-80. PubMed ID: 16217372 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]